Data from Piai et al., JAMA Otolaryngology & Neck Surgery
We collaborate with the Netherlands Quality of Life and Biomedical Cohort study in Head and Neck Cancer (NET-QUBIC) consortium to understand cognitive and speech impairment in patients diagnosed with, and undergoing treatment for, head and neck cancer.
Publications
Cognitive and speech functioning in HNC: baseline prevalence and possible causes
Background. The impact of …
Assessment of Neurocognitive Impairment and Speech Functioning Before Head and Neck Cancer Treatment
We documented cognitive and speech functioning before treatment in individuals with head and neck cancer in a prospective cohort study. Results indicated a high prevalence of speech and cognitive impairment. Patient-reported speech and cognitive function were associated with each other, whereas objective cognitive measures were not associated with patient-reported measures.
